Chitogel is a postoperative hydrogel nasal dressing that can be applied to sinuses after endoscopic sinus surgery.
The hydrogel is made by combining chitosan succinamide, dextran aldehyde, and, a sodium phosphate buffer solution.
Many patients with chronic sinusitis whose conditions fail to respond to medical treatment require surgery to return their sinus cavities to normal. Chitogel is designed to improve surgical outcomes in the treatment of sinusitis.
Chitogel addresses a number of the traditional sinus surgery shortcomings:
• Separate tissue or structures compromised by
surgical trauma
• Prevent adhesions between mucosal surfaces in the
nasal cavity
• Minimise ostial stenosis
• Control minimal bleeding by tamponade effect, blood
absorption, and platelet aggregation
• Enhance wound healing and the patient experience
Company Details
- Employees
- 6
- Founded
- -
- Address
- 175 Victoria St, Level 11,new Zealand
- Industry
- Medical Device
- Website
- chitogel.com
- Keywords
- Syntplant Ltd..
- HQ
- Te Aro, Wellington Region
Chitogel Limited Questions
Chitogel Limited's website is chitogel.com
Chitogel Limited's LinkedIn profile is https://nz.linkedin.com/company/chitogel-limited
Chitogel Limited has
6 employees.
View email and phone details for 6
employees at Chitogel Limited.
Chitogel Limited's industry is
Medical Device
Chitogel Limited's top competitors are
Evergen,
Medace Bv,
Uronurse,
Chitomed,
Pyper Vision,
Syntplant Ltd.,
Heartlab,
Dp Medical Systems Ltd,
Victory & Grace,
Xion.
Chitogel Limited's categories are Medical Device
Chitogel Limited's founding year is 2014
